- Home
- CNF vs SRTS Comparison
CNF vs SRTS Comparison
Compare CNF & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNF | SRTS |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.8M | 44.3M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CNF | SRTS |
|---|---|---|
| Price | $2.82 | $2.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 2.1K | ★ 57.2K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | $252.34 | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.37 | $2.66 |
| 52 Week High | $24.00 | $5.92 |
Technical Indicators
Market Signals| Indicator | CNF | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 46.88 |
| Support Level | $2.88 | $2.82 |
| Resistance Level | $3.60 | $3.28 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 25.00 | 67.50 |
Price Performance
Historical ComparisonAbout CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.